Fluphenazine Decanoate Injection, Solution
Product Images NDC 25021-838

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluphenazine Decanoate (NDC 25021-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Flu2q 0000 01)

Chemical structure diagram of Fluphenazine Decanoate showing its molecular formula (C32H44F3N3OS) and molecular weight (591.8). The diagram depicts the arrangement of atoms and bonds characteristic of the compound.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Flu2q 0000 02)

Label for Fluphenazine Decanoate Injection, USP, 125 mg per 5 mL (25 mg per mL) in a 5 mL multi-dose vial, for intramuscular or subcutaneous use. The label shows manufacturer information for Sagent Pharmaceuticals with manufacturing in India, storage instructions, and barcodes. The NDC listed is 25021-838-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.